| （単位：千ドル） | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上原価 | 2,847 | 5,276 | 9,998 | - | - | - | - | - | - | - | - | - | - | - |
| 研究開発費 | - | - | - | - | - | - | - | - | - | - | - | - | 2,900 | 1,177 |
| 営業費用 | 8,528 | 10,559 | 9,855 | 13,550 | 16,752 | 13,298 | 24,818 | 36,049 | 10,922 | 11,236 | 18,225 | 12,125 | 13,271 | 11,468 |
| 営業利益 | -11,376 | -15,837 | -19,855 | - | - | - | - | - | - | - | - | - | - | - |
| 経常（税引前）利益 | - | - | - | - | - | - | - | - | - | -13,912 | -16,144 | - | - | - |
| 純利益 | - | - | - | -10,684 | -15,143 | -19,605 | -19,288 | -35,684 | -10,565 | -23,574 | -16,144 | -11,121 | -7,751 | -12,657 |
| 一株あたり利益 | - | - | - | - | - | - | - | - | - | - | -0.49 | -0.25 | -0.15 | -0.22 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | - | - | -0.49 | -0.25 | -0.15 | -0.22 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - |